INTRODUCTION
Chronic mesenteric ischemia (CMI) is a rare pathology that is generally caused by atherosclerotic disease resulting in progressive stenosis or occlusion of one or more mesenteric arteries. 1 Symptoms are often nonspecific, presenting as postprandial abdominal pain, weight loss and even diarrhea. 2 Endovascular surgery isn't yet considered the golden standard, which remains open surgery, because the endovascular technique is associated with frequent reinterventions and technical limitations. Nevertheless, it is a treatment that offers shorter hospital stays and has low morbidity and mortality. 3 It is essential to treat symptomatic CMI in order to avoid progression of the disease to acute mesenteric ischemia, which occurs in 40% to 50% of these patients. 1, 4 Endovascular treatment is the most viable choice for patients with CMI and high operative risk, but percutaneous treatment of a near-occluded celiac trunk (CT) can make the procedure extremely difficult. 2, 3 It is often necessary to use alternative techniques, such as retrograde recanalization, or even hybrid approaches. 5 We describe the case of a patient with near-occlusion of the CT and occlusion of the inferior mesenteric artery (IMA) who was treated with retrograde crossing of the lesion via the superior mesenteric artery (SMA) and antegrade stenting, resulting in complete resolution of symptoms.
PART I -CLINICAL SITUATION
A 63-year-old woman was referred from the Gastrointestinal Department with a history of smoking (stopped 10 years ago), chronic arterial hypertension, chronic obstructive pulmonary disease and hypercholesterolemia, after presenting with a history of 6 months of postprandial upper abdominal pain. The patient had exhibited progressive weight loss of 4 kg during this period and showed no signs of vomiting or melena.
Colonoscopy and gastrointestinal endoscopy findings were normal. Abdominal ultrasound revealed a previous cholecystectomy with no other important results.
Computed angiotomography showed diffuse aortic atherosclerotic disease with near-occlusion of the CT, low-grade stenosis at the level of the ostium of the SMA and occlusion of the IMA (Figure 1 ). The patient was diagnosed with CMI secondary to an atherosclerotic near-occluded CT and an occluded IMA.
PART II -WHAT WAS DONE
The right common femoral artery was accessed percutaneously and a 6 Fr, 65 cm sheath (Destination; Terumo, Tokyo, Japan) was positioned into the abdominal aorta. A coaxial catheter technique with different angulated catheters (e.g., Glidecath; Terumo, Tokyo, Japan) was used to attempt an antegrade crossing of the lesion, but without success. Superselective angiography of the SMA with an angulated catheter (RIM; Cook, Indiana, USA) confirmed a near-occluded CT ostium and a well-developed connection between the SMA and the CT (Figure 2 ). A 0.018" hydrophilic guidewire (Advantage; Terumo, Tokyo, Japan) was passed into the SMA from the same diagnostic catheter, reaching the near-occlusion of the CT in the retrograde direction. A microcatheter (Renegade; Boston Scientific Corporation, Massachusetts, USA) was advanced over the wire until it reached the same point ( Figure 3 ). The lesion was then crossed with a 0.014" wire (Advantage; Terumo, Tokyo, Japan), which was followed by the microcatheter. The lesion was sequentially dilated with short 2, 3 and 4 mm over-the-wire, low profile 0.014" balloons (Armada 14; Abbott Vascular, Illinois, USA) with no sign of embolization or dissection. No imaging was performed during the ballooning process. Retrograde stenting of the lesion wasn't feasible due to tortuosity. Therefore another antegrade attempt was made, since the ostium of the CT was known. A 0.014" wire (Stabilizer, Cordis, NJ, USA) was placed into the hepatic artery in the antegrade direction, through the hole provided by the previous ballooning; no capture device was needed ( Figure 4) . The retrograde wire was retracted ( Figure 2) . The ostium was stented with a 6 x 15-mm balloon-expandable stent ( Figure 5 ) (Herculink Elite, Abbott Vascular, Illinois, USA).
Final angiography showed antegrade flow into the CT and SMA with no residual stenosis or any signs of dissection ( Figure 6 ). No complications were reported and the patient was discharged 2 days after the procedure on antiplatelet treatment consisting of 100 mg/d of aspirin combined with 75 mg/d of clopidogrel. Follow-up at 1 and 6 months with US and angiotomography showed that the CT was still patent and there were no signs of recurrence of the symptoms (Figure 7) .
DISCUSSION
Chronic mesenteric ischemia is a rare disease that is generally caused by progressive stenosis or occlusion of one or more mesenteric arteries. Several authors have discussed the minimum number of diseased vessels for symptoms to appear, based on ultrasound studies showing critical stenosis of at least one mesenteric artery in up to 17.5% of asymptomatic people over 65 years old, although other authors recognize that in 9% of chronic cases symptomatic involvement is only in one artery (5% with SMA and 4% with CT involvement). 1, 6 Classic symptoms include postprandial abdominal pain, "food fear" and weight loss, but often these symptoms are nonspecific and present real diagnostic challenges for most specialists. 1 Most patients who are diagnosed with CMI will undergo extensive investigation, with expensive and sometimes inconclusive exams. 1 Chronic mesenteric ischemia has predictive value and should be treated, since 50% of patients with acute mesenteric ischemia have previously exhibited symptoms of CMI. 4 The mortality rate among patients with acute mesenteric ischemia is as high as 40% to 50%. 6 It is an extremely debilitating disease leading to reduced quality of life and weight loss due to malnutrition.
The open surgical approach is the gold standard for treatment of CMI, but there is no consensus on the best method of revascularization. Several reports have compared open repair with endovascular treatment and the endovascular approach has achieved a high rate of technical success and lower rates of morbidity and mortality outcomes over the short term, especially when dealing with high-risk patients. 2, [6] [7] [8] The normal antegrade endovascular approach to a diseased CT is via femoral or brachial access.
In this case, we chose to use the retrograde approach via the common femoral artery. Brachial access was avoided because of the fragile appearance and very small size of the brachial artery, confirmed by ultrasound.
Stent placement was chosen because the results of ballooning were unsatisfactory and because of its superior late patency compared with percutaneous transluminal angioplasty alone for treatment of calcified ostial stenosis/occlusion. 7 Retrograde catheterization is a well-established approach for peripheral recanalization and is presented here as a feasible alternative for endovascular CMI treatment, especially when antegrade recanalization fails. 9, 10 It is also possible to exit the retrograde wire through a second access before continuing the treatment in the antegrade direction, but that technique requires a capture device. 9 Once the arterial lumen had been achieved, as confirmed by angiogram after the progressive angioplasty, we chose to continue with an antegrade approach. Stent placement was not possible via the retrograde approach because of the device's rigidity and the tortuosity of the vessels. The antegrade approach offered greater stability and enabled better accuracy for positioning the stent.
CONCLUSION
With this case we demonstrate that retrograde crossing of a CT lesion is a feasible technique, allowing antegrade catheterization and further stenting of the vessel, adding another approach to the arsenal available to vascular surgeons faced with challenging lesions and enabling more complete and less invasive treatment.
